Advertisement

Topics

Warp Drive hands antibiotic program R&D to Sanofi

04:25 EST 1 Dec 2016 | SmartBrief

Clinical research and development of Warp Drive Bio's aminoglycoside antibiotic program targeting Gram-negative bacteria will -More

Original Article: Warp Drive hands antibiotic program R&D to Sanofi

NEXT ARTICLE

More From BioPortfolio on "Warp Drive hands antibiotic program R&D to Sanofi"

Quick Search
Advertisement
 

Relevant Topic

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...